Parainfluenza Virus Type 3 Latest Advances

Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread.

Journal: Journal of virology

Published: June 03, 2026

Continued co-circulation of multiple human parainfluenza virus type 3 lineages in Fukushima and Miyagi, Japan in 2025.

Journal: Japanese journal of infectious diseases

Published: May 31, 2026

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

Journal: Science advances

Published: May 22, 2026

Use of hypoxic mixture in an infant with congenital heart disease with pulmonary hyperflow and moderate acute bronchiolitis: case report

Journal: Archivos de cardiologia de Mexico

Published: May 18, 2026

Analysis of Pathogens Detected Using Multiplex PCR in Children After the COVID-19 Pandemic.

Journal: Clinical pediatrics

Published: April 28, 2026

Pairwise Respiratory Viral Co-Detection Patterns Before, During, and After the COVID-19 Pandemic: An 18-Year Multiplex PCR Surveillance Study.

Journal: Microorganisms

Published: April 28, 2026

A fusion protein's weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein.

Journal: mBio

Published: April 14, 2026

Development of an indirect enzyme-linked immunosorbent assay based on the nucleocapsid protein of bovine parainfluenza virus type 3.

Journal: Frontiers in cellular and infection microbiology

Published: March 04, 2026

Innate airway responses shape permissiveness to human respiratory syncytial virus.

Journal: Virus research

Published: January 28, 2026

Comparing clinical and immunologic response efficacy of systemic prime versus mucosal prime and systemic boost vaccination of beef calves after coinfection with bovine respiratory syncytial virus and bovine parainfluenza virus type 3 at weaning.

Journal: The Canadian veterinary journal = La revue veterinaire canadienne

Published: January 26, 2026

Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters.

Journal: bioRxiv : the preprint server for biology

Published: December 31, 2025

Broad-Spectrum Virucidal Activity of Nitric Oxide Nasal Spray (NONS) Against SARS-CoV-2 Variants and Major Respiratory Viruses.

Journal: Viruses

Published: December 15, 2025

Parainfluenza Virus Type 3 Latest Advances

Find the Latest Research About Parainfluenza Virus Type 3

Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread.

Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread.

Continued co-circulation of multiple human parainfluenza virus type 3 lineages in Fukushima and Miyagi, Japan in 2025.

Continued co-circulation of multiple human parainfluenza virus type 3 lineages in Fukushima and Miyagi, Japan in 2025.

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

Use of hypoxic mixture in an infant with congenital heart disease with pulmonary hyperflow and moderate acute bronchiolitis: case report

Use of hypoxic mixture in an infant with congenital heart disease with pulmonary hyperflow and moderate acute bronchiolitis: case report

Analysis of Pathogens Detected Using Multiplex PCR in Children After the COVID-19 Pandemic.

Analysis of Pathogens Detected Using Multiplex PCR in Children After the COVID-19 Pandemic.

Pairwise Respiratory Viral Co-Detection Patterns Before, During, and After the COVID-19 Pandemic: An 18-Year Multiplex PCR Surveillance Study.

Pairwise Respiratory Viral Co-Detection Patterns Before, During, and After the COVID-19 Pandemic: An 18-Year Multiplex PCR Surveillance Study.

A fusion protein's weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein.

A fusion protein's weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein.

Development of an indirect enzyme-linked immunosorbent assay based on the nucleocapsid protein of bovine parainfluenza virus type 3.

Development of an indirect enzyme-linked immunosorbent assay based on the nucleocapsid protein of bovine parainfluenza virus type 3.

Innate airway responses shape permissiveness to human respiratory syncytial virus.

Innate airway responses shape permissiveness to human respiratory syncytial virus.

Comparing clinical and immunologic response efficacy of systemic prime versus mucosal prime and systemic boost vaccination of beef calves after coinfection with bovine respiratory syncytial virus and bovine parainfluenza virus type 3 at weaning.

Comparing clinical and immunologic response efficacy of systemic prime versus mucosal prime and systemic boost vaccination of beef calves after coinfection with bovine respiratory syncytial virus and bovine parainfluenza virus type 3 at weaning.

Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters.

Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters.

Broad-Spectrum Virucidal Activity of Nitric Oxide Nasal Spray (NONS) Against SARS-CoV-2 Variants and Major Respiratory Viruses.

Broad-Spectrum Virucidal Activity of Nitric Oxide Nasal Spray (NONS) Against SARS-CoV-2 Variants and Major Respiratory Viruses.